ARTICLE | Clinical News
Omeprazole tablet formulation regulatory update
January 22, 2001 8:00 AM UTC
ADRX received U.S. Patent No. 6,174,548 covering a tablet version of omeprazole to treat duodenal/gastric ulcers and gastro-esophageal reflux disease. The product, a generic version of AstraZeneca plc...